Serum tumor markers, such as CEA, SCCA, CYFRA 21-1, NSE, and ProGRP, are considered to be predictive or prognostic in NSCLC, and some of these markers have been shown to be correlated with EGFR mutations (33). This evidence concerns the gene CEACAM5 and neoplasm.